Allopurinol Orion 300 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

allopurinol orion 300 mg tablett

orion corporation - allopurinol - tablett - 300 mg - laktosmonohydrat hjälpämne; allopurinol 300 mg aktiv substans; para-orange aluminiumlack hjälpämne - allopurinol

Xeljanz Europeiska unionen - svenska - EMA (European Medicines Agency)

xeljanz

pfizer europe ma eeig - tofacitinib - artrit, reumatoid - immunsuppressiva - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 och 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Allopurinol Mylan 300 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

allopurinol mylan 300 mg tablett

mylan ab - allopurinol - tablett - 300 mg - allopurinol 300 mg aktiv substans; laktosmonohydrat hjälpämne; para-orange aluminiumlack hjälpämne

Allopurinol Mylan 100 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

allopurinol mylan 100 mg tablett

mylan ab - allopurinol - tablett - 100 mg - allopurinol 100 mg aktiv substans; laktosmonohydrat hjälpämne

Duzallo Europeiska unionen - svenska - EMA (European Medicines Agency)

duzallo

grunenthal gmbh - allopurinol, lesinurad - gikt - antigout preparat - duzallo är indicerat hos vuxna för behandling av hyperurikemi i gikt patienter som inte uppnått målet serum nivåer av urinsyra med en lämplig dos av allopurinol ensam.

Allopurinol Accord 100 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

allopurinol accord 100 mg tablett

accord healthcare b.v. - allopurinol - tablett - 100 mg - laktosmonohydrat hjälpämne; allopurinol 100 mg aktiv substans

Allopurinol Accord 300 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

allopurinol accord 300 mg tablett

accord healthcare b.v. - allopurinol - tablett - 300 mg - allopurinol 300 mg aktiv substans; laktosmonohydrat hjälpämne

Zyloric 100 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

zyloric 100 mg tablett

aspen pharma trading limited - allopurinol - tablett - 100 mg - allopurinol 100 mg aktiv substans; laktosmonohydrat hjälpämne - allopurinol

Allopurinol Teva 100 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

allopurinol teva 100 mg tablett

teva sweden ab - allopurinol - tablett - 100 mg - natriumlaurilsulfat hjälpämne; allopurinol 100 mg aktiv substans; laktosmonohydrat hjälpämne - allopurinol

Zyloric 300 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

zyloric 300 mg tablett

aspen pharma trading limited - allopurinol - tablett - 300 mg - laktosmonohydrat hjälpämne; allopurinol 300 mg aktiv substans - allopurinol